Spots Global Cancer Trial Database for mitoxantrone hydrochloride
Every month we try and update this database with for mitoxantrone hydrochloride cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia | NCT00002549 | Leukemia | filgrastim busulfan cyclophosphamid... cytarabine daunorubicin hy... etoposide idarubicin mesna mitoxantrone hy... allogeneic bone... autologous bone... peripheral bloo... radiation thera... | 15 Years - 60 Years | National Cancer Institute (NCI) | |
| Selinexor and Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | NCT02299518 | Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Recurrent Adult... Secondary Acute... | mitoxantrone hy... etoposide cytarabine selinexor laboratory biom... pharmacological... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer | NCT00546377 | Leukemia Lymphoma | filgrastim pegfilgrastim rituximab sargramostim cyclophosphamid... mitoxantrone hy... pentostatin fluorescence in... gene rearrangem... polymerase chai... protein express... flow cytometry biopsy | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia | NCT00003602 | Leukemia Myelodysplastic... | cytarabine etoposide idarubicin mitoxantrone hy... | 55 Years - | National Cancer Institute (NCI) | |
| High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer | NCT00003068 | Breast Cancer Drug/Agent Toxi... | amifostine trih... cyclophosphamid... mitoxantrone hy... thiotepa peripheral bloo... | 16 Years - 70 Years | National Cancer Institute (NCI) | |
| Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers | NCT00015951 | Leukemia Myelodysplastic... | bevacizumab cytarabine mitoxantrone hy... | 18 Years - 120 Years | University of Maryland, Baltimore | |
| Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia | NCT00003003 | Leukemia | sargramostim mitomycin C mitoxantrone hy... | 18 Years - 120 Years | Dartmouth-Hitchcock Medical Center | |
| Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma | NCT00005987 | Multiple Myelom... | carmustine cyclophosphamid... dexamethasone etoposide filgrastim mitoxantrone hy... recombinant int... sargramostim bone marrow abl... peripheral bloo... radiation thera... | - 70 Years | Masonic Cancer Center, University of Minnesota | |
| Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS | NCT02921061 | Mixed Phenotype... Previously Trea... Recurrent Adult... Recurrent High ... Refractory Acut... Refractory High... Untreated Adult... | Cladribine Cytarabine Decitabine Filgrastim Laboratory Biom... Mitoxantrone Hy... | 18 Years - | Fred Hutchinson Cancer Center | |
| Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence | NCT00003858 | Prostate Cancer | mitoxantrone hy... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia | NCT02101853 | Recurrent B Acu... | Allogeneic Hema... Asparaginase Blinatumomab Cyclophosphamid... Cytarabine Dexamethasone Etoposide Leucovorin Calc... Mercaptopurine Methotrexate Mitoxantrone Mitoxantrone Hy... Pegaspargase Pharmacological... Radiation Thera... Therapeutic Hyd... Thioguanine Vincristine Vincristine Sul... | 1 Year - 31 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia | NCT00053131 | Leukemia | filgrastim sargramostim cytarabine mitoxantrone hy... | 15 Years - | Roswell Park Cancer Institute | |
| Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia | NCT00278213 | Prolymphocytic ... | alemtuzumab cyclophosphamid... fludarabine pho... mitoxantrone hy... | 18 Years - 70 Years | German CLL Study Group | |
| Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer | NCT00002819 | Ovarian Cancer | carboplatin cyclophosphamid... mitoxantrone hy... paclitaxel autologous bone... peripheral bloo... | - 65 Years | GOG Foundation | |
| Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer | NCT00182741 | Prostate Cancer | calcitriol mitoxantrone hy... prednisone | 18 Years - 100 Years | OHSU Knight Cancer Institute | |
| Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer | NCT00003080 | Ovarian Cancer | endocrine-modul... melphalan mitoxantrone hy... tamoxifen citra... thiotepa peripheral bloo... | 18 Years - 60 Years | Fred Hutchinson Cancer Center | |
| Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia | NCT00550992 | Leukemia | anti-thymocyte ... asparaginase busulfan cyclophosphamid... cyclosporine cytarabine daunorubicin hy... etoposide leucovorin calc... melphalan mercaptopurine methotrexate mitoxantrone hy... pegaspargase prednisolone prednisone therapeutic hyd... thioguanine vincristine sul... allogeneic bone... allogeneic hema... umbilical cord ... | - 1 Year | Dutch Childhood Oncology Group | |
| Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer | NCT00004237 | Breast Cancer | cyclophosphamid... doxorubicin hyd... epirubicin hydr... mitoxantrone hy... vinorelbine tar... conventional su... radiation thera... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT00274807 | Leukemia | filgrastim cytarabine etoposide mitoxantrone hy... | 16 Years - | The Cleveland Clinic | |
| Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer | NCT00004071 | Prostate Cancer | leflunomide mitoxantrone hy... prednisone | 18 Years - | Pfizer | |
| Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia | NCT00006122 | Leukemia | cytarabine etoposide gemtuzumab ozog... idarubicin mitoxantrone hy... | 61 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | NCT00634244 | Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Recurrent Adult... | alvocidib mitoxantrone hy... carboplatin cytarabine sirolimus etoposide topotecan hydro... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT01349972 | Acute Myeloid L... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Secondary Acute... Untreated Adult... | alvocidib daunorubicin hy... mitoxantrone hy... cytarabine | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia | NCT01839240 | Adult Acute Meg... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Recurrent Adult... Secondary Acute... Untreated Adult... | azacitidine cytarabine mitoxantrone hy... laboratory biom... | 18 Years - | University of Chicago | |
| Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma | NCT00002565 | Lymphoma | bleomycin sulfa... CHOP regimen cisplatin cyclophosphamid... cytarabine doxorubicin hyd... etoposide idarubicin ifosfamide mesna methylprednisol... mitoxantrone hy... prednisone vincristine sul... | 15 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia | NCT00002549 | Leukemia | filgrastim busulfan cyclophosphamid... cytarabine daunorubicin hy... etoposide idarubicin mesna mitoxantrone hy... allogeneic bone... autologous bone... peripheral bloo... radiation thera... | 15 Years - 60 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer | NCT00003297 | Ovarian Cancer | mitoxantrone hy... thiotepa topotecan hydro... peripheral bloo... | 18 Years - | Georgetown University | |
| Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence | NCT00003858 | Prostate Cancer | mitoxantrone hy... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia | NCT05955261 | Acute Myeloid L... | Venetoclax Azacitidine Cytarabine Gemtuzumab Ozog... Daunorubicin Hy... Fludarabine Pho... Idarubicin Hydr... Mitoxantrone Hy... Etoposide Gilteritinib | 29 Days - 21 Years | St. Jude Children's Research Hospital | |
| CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | NCT01768897 | Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Recurrent Adult... | CPI-613 cytarabine mitoxantrone hy... laboratory biom... pharmacological... | 18 Years - | Wake Forest University Health Sciences | |
| Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | NCT00005867 | Lymphoma | bleomycin sulfa... CHOP regimen cyclophosphamid... doxorubicin hyd... etoposide mitoxantrone hy... prednisolone vincristine sul... | 18 Years - 59 Years | National Cancer Institute (NCI) | |
| Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome | NCT02521493 | Acute Myeloid L... Down Syndrome Myelodysplastic... Myeloid Leukemi... Myeloproliferat... | Asparaginase Asparaginase Er... Cytarabine Daunorubicin Hy... Etoposide Laboratory Biom... Mitoxantrone Hy... Thioguanine | 91 Days - 3 Years | Children's Oncology Group | |
| Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia | NCT00268242 | Leukemia | Gemcitabine Hyd... Mitoxantrone Hy... | 18 Years - | The Cleveland Clinic | |
| Testing the Addition of an Anti-cancer Drug, M3814, to the Usual Treatment (Mitoxantrone, Etoposide, and Cytarabine) for Relapsed or Refractory Acute Myeloid Leukemia | NCT03983824 | Recurrent Acute... Refractory Acut... | Cytarabine Etoposide Phosp... Mitoxantrone Hy... Peposertib | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia | NCT00052299 | Leukemia | cytarabine etoposide gemtuzumab ozog... idarubicin mitoxantrone hy... | 61 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia | NCT00002531 | Leukemia | asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... etoposide ifosfamide leucovorin calc... mercaptopurine methotrexate mitoxantrone hy... prednisolone teniposide thioguanine vincristine sul... vindesine allogeneic bone... peripheral bloo... radiation thera... | 15 Years - 65 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia | NCT00003436 | Leukemia Myelodysplastic... | amsacrine asparaginase cytarabine daunorubicin hy... etoposide methotrexate mitoxantrone hy... therapeutic hyd... allogeneic bone... | - 15 Years | National Cancer Institute (NCI) | |
| Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer | NCT00003183 | Prostate Cancer | filgrastim mitoxantrone hy... | - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer | NCT00010075 | Breast Cancer | fluorouracil leucovorin calc... mitoxantrone hy... | 75 Years - 90 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia | NCT00967057 | Leukemia | asparaginase dexamethasone idarubicin methotrexate mitoxantrone hy... pegaspargase vincristine sul... | 1 Year - 18 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia | NCT00003405 | Leukemia | recombinant int... amifostine trih... bromodeoxyuridi... cytarabine idarubicin idoxuridine isotretinoin mitoxantrone hy... | 0 Years - 70 Years | Rush University Medical Center | |
| Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia | NCT00002658 | Leukemia Neutropenia | filgrastim amsacrine cyclophosphamid... cytarabine daunorubicin hy... etoposide idarubicin mitoxantrone hy... thioguanine tretinoin allogeneic bone... autologous bone... peripheral bloo... radiation thera... | 15 Years - | National Cancer Institute (NCI) | |
| Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes | NCT02044796 | Acute Biphenoty... de Novo Myelody... Previously Trea... Recurrent Adult... Untreated Adult... Secondary Acute... | Cladribine Cytarabine Filgrastim Laboratory Biom... Mitoxantrone Hy... | 18 Years - | Fred Hutchinson Cancer Center | |
| Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia | NCT00002912 | Leukemia | etoposide mitoxantrone hy... valspodar | - 21 Years | National Cancer Institute (NCI) | |
| A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years | NCT00079105 | Lymphoma | bleomycin sulfa... cyclophosphamid... etoposide mitoxantrone hy... prednisolone procarbazine hy... vinblastine sul... | 60 Years - 120 Years | Newcastle-upon-Tyne Hospitals NHS Trust | |
| Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma | NCT00002259 | Sarcoma, Kaposi HIV Infections | Mitoxantrone hy... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma | NCT00002576 | Lymphoma | cyclophosphamid... doxorubicin hyd... mitoxantrone hy... prednisolone vincristine sul... | 65 Years - | National Cancer Institute (NCI) | |
| High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer | NCT00003032 | Breast Cancer | filgrastim cisplatin cyclophosphamid... mitoxantrone hy... tamoxifen citra... | 16 Years - 60 Years | Canadian Cancer Trials Group | |
| Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia | NCT01127009 | Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Recurrent Adult... | bortezomib mitoxantrone hy... etoposide cytarabine flow cytometry | 18 Years - 70 Years | Case Comprehensive Cancer Center | |
| Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia | NCT00003405 | Leukemia | recombinant int... amifostine trih... bromodeoxyuridi... cytarabine idarubicin idoxuridine isotretinoin mitoxantrone hy... | 0 Years - 70 Years | Rush University Medical Center | |
| CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma | NCT02484391 | Granulocytic Sa... Recurrent Adult... | 6,8-Bis(benzylt... Cytarabine Hematopoietic C... Mitoxantrone Hy... | 18 Years - | Wake Forest University Health Sciences | |
| Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma | NCT00317408 | Lymphoma | anti-thymocyte ... busulfan carboplatin carmustine cyclosporine cytarabine dexamethasone etoposide phosp... idarubicin ifosfamide leucovorin calc... lomustine melphalan methotrexate mitoxantrone hy... prednisolone thiotepa vinblastine sul... vindesine allogeneic hema... autologous hema... peripheral bloo... total-body irra... | - 21 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma | NCT00317408 | Lymphoma | anti-thymocyte ... busulfan carboplatin carmustine cyclosporine cytarabine dexamethasone etoposide phosp... idarubicin ifosfamide leucovorin calc... lomustine melphalan methotrexate mitoxantrone hy... prednisolone thiotepa vinblastine sul... vindesine allogeneic hema... autologous hema... peripheral bloo... total-body irra... | - 21 Years | National Cancer Institute (NCI) | |
| Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia | NCT00002700 | Leukemia Lymphoma | asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... leucovorin calc... mercaptopurine methotrexate mitoxantrone hy... prednisolone prednisone therapeutic hyd... vincristine sul... allogeneic bone... autologous bone... radiation thera... | 15 Years - 60 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | NCT01904643 | Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Recurrent Adult... | lenalidomide mitoxantrone hy... etoposide cytarabine | 18 Years - | Stanford University | |
| Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast Cancer | NCT00002544 | Breast Cancer | docetaxel mitoxantrone hy... | - 80 Years | National Cancer Institute (NCI) | |
| Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma | NCT01403415 | Childhood B Acu... Childhood T Acu... Mature T-Cell a... Recurrent Child... Recurrent Child... | Dexamethasone Laboratory Biom... Methotrexate Mitoxantrone Hy... Pegaspargase Pharmacological... Temsirolimus Vincristine Sul... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia | NCT00470197 | Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Malignant Neopl... Recurrent Adult... Recurrent Adult... | alvocidib cytarabine mitoxantrone hy... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia | NCT02339740 | Acute Promyeloc... | Arsenic Trioxid... Cytarabine Dexamethasone Idarubicin Laboratory Biom... Mitoxantrone Hy... Quality-of-Life... Questionnaire A... Tretinoin | 12 Months - 21 Years | Children's Oncology Group | |
| Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | NCT00005847 | Prostate Cancer | recombinant int... estramustine ph... isotretinoin mitoxantrone hy... paclitaxel vinorelbine dit... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes | NCT00028899 | Leukemia Myelodysplastic... | asparaginase cytarabine gemtuzumab ozog... mitoxantrone hy... | - 21 Years | Children's Oncology Group | |
| Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant | NCT00107354 | Leukemia Myelodysplastic... | aldesleukin therapeutic all... therapeutic aut... cytarabine etoposide mitoxantrone hy... allogeneic bone... peripheral bloo... | 14 Years - | Fred Hutchinson Cancer Center | |
| Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm | NCT03012672 | Acute Leukemia ... Acute Myeloid L... Myeloid Neoplas... | Cladribine Cytarabine Granulocyte Col... Mitoxantrone Hy... Quality-of-Life... Questionnaire A... | 18 Years - | University of Washington | |
| Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer | NCT00003080 | Ovarian Cancer | endocrine-modul... melphalan mitoxantrone hy... tamoxifen citra... thiotepa peripheral bloo... | 18 Years - 60 Years | Fred Hutchinson Cancer Center | |
| Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease | NCT00005998 | Lymphoma | carmustine cyclophosphamid... cytarabine dexamethasone etoposide filgrastim mitoxantrone hy... retrovirus vect... in vitro-treate... peripheral bloo... radiation thera... | 18 Years - 70 Years | Masonic Cancer Center, University of Minnesota | |
| Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast Cancer | NCT00002544 | Breast Cancer | docetaxel mitoxantrone hy... | - 80 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia | NCT00002598 | Leukemia | recombinant int... sargramostim cyclophosphamid... cytarabine etoposide methotrexate mitoxantrone hy... bone marrow abl... radiation thera... | 16 Years - | Memorial Sloan Kettering Cancer Center | |
| Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia | NCT01839240 | Adult Acute Meg... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Recurrent Adult... Secondary Acute... Untreated Adult... | azacitidine cytarabine mitoxantrone hy... laboratory biom... | 18 Years - | University of Chicago | |
| Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia | NCT01174888 | Acute Myeloid L... Acute Myeloid L... Myelodysplastic... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Recurrent Adult... Secondary Acute... | midostaurin Bortezomib mitoxantrone hy... etoposide cytarabine | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia | NCT00006122 | Leukemia | cytarabine etoposide gemtuzumab ozog... idarubicin mitoxantrone hy... | 61 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation | NCT00609739 | Leukemia | cyclosporine cytarabine filgrastim methotrexate methylprednisol... mitoxantrone hy... allogeneic bone... umbilical cord ... Cis-Retinoic ac... | - 18 Years | Masonic Cancer Center, University of Minnesota | |
| Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT00407966 | Adult Acute Bas... Adult Acute Eos... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Secondary Acute... Untreated Adult... | alvocidib cytarabine mitoxantrone hy... | 18 Years - | National Cancer Institute (NCI) | |
| Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma | NCT00005987 | Multiple Myelom... | carmustine cyclophosphamid... dexamethasone etoposide filgrastim mitoxantrone hy... recombinant int... sargramostim bone marrow abl... peripheral bloo... radiation thera... | - 70 Years | Masonic Cancer Center, University of Minnesota | |
| Ixazomib, Mitoxantrone Hydrochloride, Etoposide, and Intermediate-Dose Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia | NCT02070458 | Recurrent Adult... Refractory Acut... | ixazomib mitoxantrone hy... etoposide cytarabine | 18 Years - 70 Years | Case Comprehensive Cancer Center | |
| Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia | NCT02339740 | Acute Promyeloc... | Arsenic Trioxid... Cytarabine Dexamethasone Idarubicin Laboratory Biom... Mitoxantrone Hy... Quality-of-Life... Questionnaire A... Tretinoin | 12 Months - 21 Years | Children's Oncology Group | |
| Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy | NCT00070174 | Leukemia | asparaginase busulfan cyclophosphamid... cyclosporine cytarabine daunorubicin hy... etoposide gemtuzumab ozog... methotrexate mitoxantrone hy... allogeneic bone... | - | Children's Oncology Group | |
| Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome | NCT00002805 | Leukemia | filgrastim cladribine cytarabine etoposide methotrexate mitoxantrone hy... therapeutic hyd... allogeneic bone... autologous bone... peripheral bloo... low-LET cobalt-... low-LET electro... low-LET photon ... | - 21 Years | Children's Oncology Group | |
| Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML | NCT00003407 | Drug/Agent Toxi... Leukemia Myelodysplastic... Neutropenia | amifostine trih... cytarabine mitoxantrone hy... | 18 Years - 120 Years | Rush University Medical Center | |
| Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm | NCT03012672 | Acute Leukemia ... Acute Myeloid L... Myeloid Neoplas... | Cladribine Cytarabine Granulocyte Col... Mitoxantrone Hy... Quality-of-Life... Questionnaire A... | 18 Years - | University of Washington | |
| Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia | NCT00006122 | Leukemia | cytarabine etoposide gemtuzumab ozog... idarubicin mitoxantrone hy... | 61 Years - | European Organisation for Research and Treatment of Cancer - EORTC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
